Anti-AAV8 + AAV3B antibody [HL2383-IgG1] - BSA and Azide free
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Mouse Recombinant Monoclonal AAV8 antibody. Carrier free. Suitable for I-ELISA, Dot and reacts with Recombinant fragment - Adeno-associated virus 3B, Recombinant fragment - Adeno-associated virus - 8 samples.
View Alternative Names
Adeno-associated virus - 8
- I-ELISA
Lab
Indirect ELISA - Anti-AAV8 + AAV3B antibody [HL2383-IgG1] - BSA and Azide free (AB315830)
This data was developed using ab315829, the same antibody clone in a different buffer formulation.
Indirect ELISA showing ab315829 binding to AAV8 & AAV3B empty capsid. Binding of ab315829 was assessed in a serial dilution and EC-50 is 1.234 ng/ml for AAV8 and 6.202 ng/ml for AAV3B. The secondary antibody used was Goat Anti-Mouse IgG H&L (HRP) preadsorbed at 1/2000 dilution.
Antigen : AAV1 empty capsid,AAV2 empty capsid,AAV5 empty capsid,AAV6 empty capsid,AAV8 empty capsid,AAV9 empty capsid AAV3B empty capsid.
Antigen concentration : 7.5E+10 vp/mL
- Dot
Supplier Data
Dot Blot - Anti-AAV8 + AAV3B antibody [HL2383-IgG1] - BSA and Azide free (AB315830)
This data was developed using ab315829, the same antibody clone in a different buffer formulation.
Dot blot analysis of AAV8 + AAV3B using ab315829 at 1 : 2000 (0.5 ug/ml) followed by a Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1 : 5000 dilution.
Dot blot was performed using 1 ng of each capsid loaded per well.
Anti-AAV9 antibody [HL2368] (ab315818) (1 : 2000), Anti-AAV9 antibody [HL2370] (ab315820) (1 : 2000), Anti-AAV9 antibody [HL2374] (ab315823) (1 : 2000), and Anti-AAV9 antibody [HL2374-IgG1] - BSA and Azide free (ab315826) (1 : 2000) specifically recognize AAV9 capsid.
Anti-AAV8 + AAV3B antibody [HL2383] (ab315827) (1 : 2000), and Anti-AAV8 + AAV3B antibody [HL2383-IgG1] (ab315829) (1 : 2000) specifically recognize AAV8/3B capsid.
Anti-AAV8 + AAV9 antibody [HL2372] (ab315821) (1 : 2000) specifically recognizes AAV8/9 capsid.
Anti-AAV5 antibody [HL2476] (ab315831) (1 : 2000) specifically recognizes AAV5 capsid.
true
Exposure time: 8min
Related conjugates and formulations (1)
-
Anti-AAV8 + AAV3B antibody [HL2383-IgG1]
Reactivity data
Product details
ab315830 is the carrier-free version of ab315829.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
AAV8 and AAV3B lack replicative properties in the absence of a helper virus making them a safe choice for gene delivery systems. Unlike proteins that are part of a complex these viruses exist independently but rely on the host cellular machinery for successful transduction. Through their distinct tissue tropisms these serotypes enable targeted delivery of genetic material which enhances therapeutic outcomes.
Pathways
AAV8 and AAV3B integrate into host cell processes by hijacking the endosomal trafficking and nuclear import pathways. They remain episomal avoiding integration into the host genome reducing the risk of insertional mutagenesis. AAV3B specifically associates with serotypes like AAV2 in receptor binding and entry pathways which can impact its efficacy and targeting strategy in therapeutic applications.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com